Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHD
- 1 June 2011
- journal article
- research article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 127 (6), e1406-e1413
- https://doi.org/10.1542/peds.2010-1260
Abstract
OBJECTIVE: To assess the efficacy and safety of clonidine hydrochloride extended-release tablets (CLON-XR) combined with stimulants (ie, methylphenidate or amphetamine) for attention-deficit/hyperactivity disorder (ADHD). PATIENTS AND METHODS: In this phase 3, double-blind, placebo-controlled trial, children and adolescents with hyperactive- or combined-subtype ADHD who had an inadequate response to their stable stimulant regimen were randomized to receive CLON-XR or placebo in combination with their baseline stimulant medication. Predefined efficacy measures evaluated change from baseline to week 5. Safety was assessed by spontaneously reported adverse events, vital signs, electrocardiogram recordings, and clinical laboratory values. Improvement from baseline for all efficacy measures was evaluated using analysis of covariance. RESULTS: Of 198 patients randomized, 102 received CLON-XR plus stimulant and 96 received placebo plus stimulant. At week 5, greater improvement from baseline in ADHD Rating Scale IV (ADHD-RS-IV) total score (95% confidence interval: −7.83 to −1.13; P = .009), ADHD-RS-IV hyperactivity and inattention subscale scores (P = .014 and P = .017, respectively), Conners' Parent Rating Scale scores (P < .062), Clinical Global Impression of Severity (P = .021), Clinical Global Impression of Improvement (P = .006), and Parent Global Assessment (P = .001) was observed in the CLON-XR plus stimulant group versus the placebo plus stimulant group. Adverse events and changes in vital signs in the CLON-XR group were generally mild. CONCLUSIONS: The results of this study suggest that CLON-XR in combination with stimulants is useful in reducing ADHD in children and adolescents with partial response to stimulants.Keywords
This publication has 19 references indexed in Scilit:
- Comorbid Problems in ADHD: Degree of Association, Shared Endophenotypes, and Formation of Distinct Subtypes. Implications for a Future DSMJournal of Abnormal Child Psychology, 2009
- Randomised Controlled Study-efficacy of Clonidine versus Carbamazepine in Children with ADHDJournal of Tropical Pediatrics, 2008
- Evolution of the treatment of attention-deficit/hyperactivity disorder in children: A reviewClinical Therapeutics, 2008
- Prevalence, Recognition, and Treatment of Attention-Deficit/Hyperactivity Disorder in a National Sample of US ChildrenArchives of Pediatrics & Adolescent Medicine, 2007
- Long-Term Stimulant Medication Treatment of Attention-Deficit/Hyperactivity DisorderJournal of Developmental & Behavioral Pediatrics, 2006
- A Randomized Controlled Trial of Clonidine Added to Psychostimulant Medication for Hyperactive and Aggressive ChildrenJournal of the American Academy of Child & Adolescent Psychiatry, 2003
- Treatment of ADHD in children with ticsNeurology, 2002
- A Pilot Study of Methyiphenidate, Clonidine, or the Combination in ADHD Comorbid with Aggressive Oppositional Defiant or Conduct DisorderClinical Pediatrics, 2000
- Clonidine Therapy for Comorbid Attention Deficit Hyperactivity Disorder and Conduct Disorder: Preliminary Findings in a Childrenʼs Inpatient UnitSouthern Medical Journal, 1994
- Clonidine Benefits Children with Attention Deficit Disorder and Hyperactivity: Report of a Double-Blind Placebo-Crossover Therapeutic TrialJournal of the American Academy of Child Psychiatry, 1985